Xbrane Biopharma AB (XBRANE) — Free Cash Flow Generation Index

Latest as of December 2024: 0.82x

Xbrane Biopharma AB (XBRANE) has a Free Cash Flow Generation Index of 0.82x as of December 2024. Free cash flow of Skr76.61 Million represents 1% of operating cash flow (Skr93.91 Million). See XBRANE net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.82x

Free Cash Flow / Operating CF

Free Cash Flow

Skr76.61 Million

SEK

Operating Cash Flow

Skr93.91 Million

SEK

Capital Expenditures

Skr17.30 Million

SEK

Xbrane Biopharma AB Free Cash Flow Generation Index (2018–2018)

Historical FCF Generation Index trend for Xbrane Biopharma AB across 1 annual periods. Explore Xbrane Biopharma AB (XBRANE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Xbrane Biopharma AB (2018–2018)

Year-by-year Free Cash Flow Generation Index for Xbrane Biopharma AB. For the full company profile including market capitalisation, see XBRANE company net worth.

Year	FCG Index	Free Cash Flow (SEK)	Operating CF	Capital Expenditures	YoY Change
2018	0.97x	Skr45.11 Million	Skr46.71 Million	Skr1.60 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).